← Leaderboards
Richard H Guy
University Of Geneva
$2,491,416
Attributed
$4,328,911
Total exposure
3
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $500K · FY2005–22$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
FDA$3,599,911 · 2
NIH$729,000 · 1
By mechanism
U01$3,599,911 · 2
R01$729,000 · 1
Top collaborators
- Annette L Bunge5 shared
- M. Begona Delgado-Charro5 shared
- Audra L Stinchcomb5 shared
- Stephen W. Hoag3 shared
Others in their field
Top investigators on “Bioengineering /Biomedical Engineering”
- Robert Jay Greenberg · Second Sight Medical Products, Inc.$13,197,584
- Jingyue Ju · Columbia University Health Sciences$10,991,231
- Jeffrey Rifkin · Lyncean Technologies, Inc.$9,577,715
- Daniel J Ehrlich · Whitehead Institute For Biomedical Res$8,908,616
- Mark H Ellisman · University Of California, San Diego$7,731,860
- William A Smith · Cleveland Clinic Foundation$7,551,249
Research focus
Bioengineering /Biomedical EngineeringBiosensor DevicePhenylketonuriaTechnology /Technique DevelopmentBipolar DepressionChromatographyClinical ResearchDiabetes MellitusElectric FieldElectrochemistryEuropeGlucoseHuman SubjectPhenylalanineBiomedical Equipment DevelopmentSkinBlood GlucoseLithiumNoninvasive DiagnosisPatient Monitoring DevicePatient Oriented ResearchIontophoresis TherapyNontherapeutic IontophoresisMembrane Permeability
Grant awards (13)
Assessing the skin pharmacokinetics of topical drugs, and the bio(in)equivalence of topical drug products, using non-invasive techniques$249,919
U01 · FY2022 · FD · contact PI
Assessing the skin pharmacokinetics of topical drugs, and the bio(in)equivalence of topical drug products, using non-invasive techniques$249,999
U01 · FY2021 · FD · contact PI
Assessing the skin pharmacokinetics of topical drugs, and the bio(in)equivalence of topical drug products, using non-invasive techniques$249,999
U01 · FY2020 · FD · contact PI
Assessing the skin pharmacokinetics of topical drugs, and the bio(in)equivalence of topical drug products, using non-invasive techniques$250,000
U01 · FY2019 · FD · contact PI
Assessing the skin pharmacokinetics of topical drugs, and the bio(in)equivalence of topical drug products, using non-invasive techniques$250,000
U01 · FY2018 · FD · contact PI
Bioequivalence of topical drug products: in vitro - in vivo correlations$499,999
U01 · FY2017 · FD
Bioequivalence of topical drug products: in vitro - in vivo correlations$350,000
U01 · FY2016 · FD
Bioequivalence of topical drug products: in vitro - in vivo correlations$499,999
U01 · FY2015 · FD
Bioequivalence of topical drug products: in vitro - in vivo correlations$499,998
U01 · FY2014 · FD
Bioequivalence of topical drug products: in vitro - in vivo correlations$499,998
U01 · FY2013 · FD
Skin Bioengineering: Noninvasive Transdermal Monitoring$243,000
R01 · FY2005 · EB
Skin Bioengineering: Noninvasive Transdermal Monitoring$243,000
R01 · FY2004 · EB
Skin Bioengineering: Noninvasive Transdermal Monitoring$243,000
R01 · FY2003 · EB